Literature DB >> 19560276

Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.

L Alvarez1, G Moreno, L Moreno, L Ceballos, L Shaw, I Fairweather, C Lanusse.   

Abstract

The benzimidazole compounds albendazole (ABZ) and triclabendazole (TCBZ) are both effective against Fasciola hepatica, although ABZ is only effective against adult flukes. Additionally, ABZ is a broad-spectrum nematodicidal compound with well-known ovicidal activity. However, no data on the ovicidal effect of TCBZ against F. hepatica eggs are available. The work reported here evaluated the comparative ovicidal effect of ABZ, TCBZ and their sulphoxide metabolites on F. hepatica eggs recovered from bile of sheep artificially infected with either a TCBZ-susceptible (Cullompton) or a TCBZ-resistant (Sligo) isolate of F. hepatica. Additionally, the effects of different non-flukicidal methylcarbamate benzimidazole compounds on the hatching of F. hepatica eggs were evaluated. Eggs (500 eggs/mL, n=4) were incubated for 12h either with TCBZ, TCBZ sulphoxide (TCBZ.SO), ABZ (5, 10 and 20 nmol/mL) or without drug (untreated control) (Experiment 1). Additionally, the effect of TCBZ and TCBZ.SO (5 nmol/mL) on egg hatchability was examined after a long (15 days) drug exposure (Experiment 2). Furthermore, the ovicidal effect of ABZ and ABZ.SO at different concentrations (5, 1, 0.5, 0.1 and 0.05 nmol/mL) (Experiment 3), and the effect of fenbendazole (FBZ), oxfendazole (OFZ), mebendazole (MBZ), flubendazole (FLBZ) (5 nmol/mL) and reduced-FLBZ (R-FLBZ) (2 microg/mL) on fluke eggs, were evaluated after a 12-h exposure (Experiment 4). Egg hatch was assessed by direct microscopic observation after incubation at 25 degrees C for 15 days. TCBZ and TCBZ.SO did not affect egg hatch after a 12-h incubation. A similar result was obtained after a much longer drug exposure (15 days) (Experiment 1 and 2). However, a significant (P<0.05) inhibition of egg hatch was observed in ABZ- and ABZ.SO-incubated eggs (Experiments 1 and 3). Additionally, the non-flukicidal compounds (Experiment 4) affected egg hatchability, particularly FLBZ and R-FLBZ. In conclusion, ABZ and ABZ.SO had a clear inhibitory effect on egg development of F. hepatica. However, the most extensively used flukicidal compound, TCBZ, and its main sulphoxide metabolite, did not affect egg hatch, even in TCBZ-susceptible flukes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560276     DOI: 10.1016/j.vetpar.2009.05.014

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  16 in total

1.  Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.

Authors:  Laura Ceballos; Celina Elissondo; Sergio Sánchez Bruni; Guillermo Denegri; Carlos Lanusse; Luis Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep.

Authors:  Luis A Gomez-Puerta; Cesar Gavidia; Maria T Lopez-Urbina; Hector H Garcia; Armando E Gonzalez
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

3.  In vitro ovicidal activity of Peganum harmala seeds extract on the eggs of Fasciola hepatica.

Authors:  Mohammad Moazeni; Zahra Sadat Saadaty Ardakani; Mohammad Jamal Saharkhiz; Jafar Jalaei; Ali Asghar Khademolhoseini; Shahab Shams Esfand Abad; Amir Mootabi Alavi
Journal:  J Parasit Dis       Date:  2016-08-29

4.  Liver fluke β-tubulin isotype 2 binds albendazole and is thus a probable target of this drug.

Authors:  Emma Chambers; Louise A Ryan; Elizabeth M Hoey; Alan Trudgett; Neil V McFerran; Ian Fairweather; David J Timson
Journal:  Parasitol Res       Date:  2010-07-31       Impact factor: 2.289

5.  Ovicidal effect of the methanolic extract of ginger (Zingiber officinale) on Fasciola hepatica eggs: an in vitro study.

Authors:  Mohammad Moazeni; Ali Asghar Khademolhoseini
Journal:  J Parasit Dis       Date:  2014-09-09

Review 6.  Fasciolosis-An Increasing Challenge in the Sheep Industry.

Authors:  Snorre Stuen; Cecilie Ersdal
Journal:  Animals (Basel)       Date:  2022-06-08       Impact factor: 3.231

7.  Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.

Authors:  Laura Ceballos; Laura Moreno; Juan J Torrado; Carlos Lanusse; Luis Alvarez
Journal:  BMC Vet Res       Date:  2012-05-28       Impact factor: 2.741

8.  Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay.

Authors:  David Robles-Pérez; José Manuel Martínez-Pérez; Francisco Antonio Rojo-Vázquez; María Martínez-Valladares
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

9.  First report of closantel treatment failure against Fasciola hepatica in cattle.

Authors:  Adam Novobilský; Johan Höglund
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-08-28       Impact factor: 4.077

10.  The anti-fasciolasis properties of silver nanoparticles produced by Trichoderma harzianum and their improvement of the anti-fasciolasis drug triclabendazole.

Authors:  Youssuf A Gherbawy; Ismail M Shalaby; Mahmoud Syed Abd El-Sadek; Hesham M Elhariry; Banaja A Abdelilah
Journal:  Int J Mol Sci       Date:  2013-11-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.